{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:20:58Z","timestamp":1770884458162,"version":"3.50.1"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Renmin Hospital of Hubei University of Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Polymyxins are generally recommended to be used in combination with other antibiotics for improving their antibacterial effects. As for treating carbapenem-resistant Acinetobacter baumannii infections, which antibiotic is the best option for polymyxin B-based combination therapy is still under debate. Resveratrol, a natural compound that can be well-tolerated by the human body, may have potential value in the polymyxin B-based combination therapy against carbapenem-resistant A. baumannii infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>With checkerboard assays and time-killing studies, we have found that resveratrol increased the sensitivity of carbapenem-resistant A. baumannii to polymyxin B and enhanced the bactericidal activity of polymyxin B against carbapenem-resistant A. baumannii. With biofilm formation studies, we have confirmed that resveratrol potentiated the antibiofilm activity of polymyxin B and improved its bactericidal activity against the bacterial cells with established biofilms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Resveratrol potentiates the antibiofilm and antibacterial activity of polymyxin B against carbapenem-resistant A. baumannii. Polymyxin B used in combination with resveratrol may have better clinical efficacy than polymyxin B monotherapy in the treatment of carbapenem-resistant A. baumannii infections.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jambio\/lxaf240","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T14:47:22Z","timestamp":1758725242000},"source":"Crossref","is-referenced-by-count":1,"title":["Resveratrol potentiates the antibiofilm and antibacterial activity of polymyxin B against carbapenem-resistant <i>Acinetobacter baumannii<\/i>"],"prefix":"10.1093","volume":"136","author":[{"given":"Yanhong","family":"Li","sequence":"first","affiliation":[{"name":"Renmin Hospital, Hubei University of Medicine Department of Pulmonary and Critical Care Medicine, , Shiyan, Hubei 442000 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wu","sequence":"additional","affiliation":[{"name":"Renmin Hospital, Hubei University of Medicine Department of Clinical Laboratory, , Shiyan, Hubei 442000 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[{"name":"Danjiangkou Frist Hospital Department of Endocrinology, , Shiyan, Hubei 442000 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwu","family":"Hu","sequence":"additional","affiliation":[{"name":"Renmin Hospital, Hubei University of Medicine Department of Clinical Laboratory, , Shiyan, Hubei 442000 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijun","family":"Wang","sequence":"additional","affiliation":[{"name":"Renmin Hospital, Hubei University of Medicine Department of Clinical Laboratory, , Shiyan, Hubei 442000 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxin","family":"Liang","sequence":"additional","affiliation":[{"name":"Renmin Hospital, Hubei University of Medicine Department of Clinical Laboratory, , Shiyan, Hubei 442000 ,","place":["P.R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"2025100905320898100_bib1","doi-asserted-by":"publisher","first-page":"e8606","DOI":"10.5812\/jjm.8606","article-title":"Assessment of biofilm formation and resistance to imipenem and ciprofloxacin\u00a0among clinical isolates of Acinetobacter baumannii in Tehran","volume":"7","author":"Abdi-Ali","year":"2014","journal-title":"Jundishapur J Microbiol"},{"key":"2025100905320898100_bib2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/phar.1537","article-title":"Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use","volume":"35","author":"Bergen","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2025100905320898100_bib3","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.04110-14","article-title":"Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii","volume":"59","author":"Bowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2025100905320898100_bib4","first-page":"e26","article-title":"\u00a0Ventilator-associated pneumonia and its responsible germs; an epidemiological study","volume":"5","author":"Bozorgmehr","year":"2017","journal-title":"Emerg (Tehran)"},{"key":"2025100905320898100_bib5","doi-asserted-by":"publisher","first-page":"9003","DOI":"10.1158\/0008-5472.CAN-10-2364","article-title":"Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis","volume":"70","author":"Brown","year":"2010","journal-title":"Cancer Res"},{"key":"2025100905320898100_bib6","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"2025100905320898100_bib7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/14787210.2018.1417036","article-title":"Biofilm-related disease","volume":"16","author":"Del\u00a0Pozo","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025100905320898100_bib8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/ijms18051077","article-title":"Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers\u00a0independently from the multidrug resistant phenotype","volume":"18","author":"Di\u00a0Domenico","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025100905320898100_bib9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"Drlica","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025100905320898100_bib10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2165\/11530630-000000000-00000","article-title":"Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study","volume":"12","author":"Fabbrocini","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"2025100905320898100_bib11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3121\/cmr.4.2.138","article-title":"The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature","volume":"4","author":"Falagas","year":"2006","journal-title":"Clin Med Res"},{"key":"2025100905320898100_bib12","doi-asserted-by":"publisher","first-page":"e01367","DOI":"10.1128\/AAC.01367-17","article-title":"Pharmacokinetic\/\u00a0toxicodynamic analysis\u00a0of\u00a0colistin-associated acute kidney injury\u00a0in\u00a0critically ill patients","volume":"61","author":"Forrest","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025100905320898100_bib13","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2025100905320898100_bib14","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1186\/cc11357","article-title":"Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept","volume":"16","author":"Gil-Perotin","year":"2012","journal-title":"Crit Care"},{"key":"2025100905320898100_bib15","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.2147\/IDR.S386641","article-title":"Molecular characterization of carbapenem-resistant Acinetobacter baumannii with special reference to carbapenemases: a systematic review","volume":"15","author":"Gupta","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2025100905320898100_bib16","doi-asserted-by":"publisher","first-page":"e000306","DOI":"10.1099\/mgen.0.000306","article-title":"Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii","volume":"5","author":"Hamidian","year":"2019","journal-title":"Microb Genom"},{"key":"2025100905320898100_bib17","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3389\/fmicb.2016.01065","article-title":"Anti-biofilm activities from resveratrol against Fusobacterium nucleatum","volume":"7","author":"He","year":"2016","journal-title":"Front Microbiol"},{"key":"2025100905320898100_bib18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ijantimicag.2016.08.020","article-title":"Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate","volume":"48","author":"Horcajada","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"2025100905320898100_bib19","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1007\/s11033-021-06690-6","article-title":"Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals","volume":"48","author":"Ibrahim","year":"2021","journal-title":"Mol Biol Rep"},{"key":"2025100905320898100_bib20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/phar.1493","article-title":"Adverse reactions associated with systemic polymyxin therapy","volume":"35","author":"Justo","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2025100905320898100_bib21","doi-asserted-by":"publisher","first-page":"e24814","DOI":"10.1002\/jcla.24814","article-title":"Antimicrobial resistance and biofilm formation capacity among Acinetobacter baumannii strains isolated from patients with burns and ventilator-associated pneumonia","volume":"37","author":"Khoshnood","year":"2023","journal-title":"Clin Lab Anal"},{"key":"2025100905320898100_bib22","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/ijms20112704","article-title":"Resveratrol action on lipid metabolism in cancer","volume":"20","author":"Kiskova","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025100905320898100_bib23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4103\/ijmm.IJMM_17_189","article-title":"An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies","volume":"35","author":"Laishram","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"2025100905320898100_bib24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"2025100905320898100_bib25","doi-asserted-by":"publisher","first-page":"001136","DOI":"10.1099\/mic.0.001136","article-title":"Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort","volume":"168","author":"Ledger","year":"2022","journal-title":"Microbiology (Reading)"},{"key":"2025100905320898100_bib26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41429-023-00631-0","article-title":"In vitro activity of ceftazidime\/avibactam, imipenem\/relebactam and meropenem\/vaborbactam alone or in combination with polymyxin B against carbapenem resistant Acinetobacter baumannii","volume":"76","author":"Liang","year":"2023","journal-title":"J Antibiot"},{"key":"2025100905320898100_bib27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/molecules26010229","article-title":"Anti-inflammatory action and mechanisms of resveratrol","volume":"26","author":"Meng","year":"2021","journal-title":"Molecules"},{"key":"2025100905320898100_bib28","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1185\/03007995.2014.938731","article-title":"Resveratrol plus carboxymethyl-beta-glucan reduces nasal symptoms in children with pollen-induced allergic rhinitis","volume":"30","author":"Miraglia\u00a0Del\u00a0Giudice","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"2025100905320898100_bib29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12038-021-00209-8","article-title":"Polymyxins, the last-resort antibiotics: mode of action, resistance emergence, and potential solutions","volume":"46","author":"Mohapatra","year":"2021","journal-title":"J Biosci"},{"key":"2025100905320898100_bib30","doi-asserted-by":"publisher","first-page":"e0226023","DOI":"10.1128\/mbio.02260-23","article-title":"A global view on carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Muller","year":"2023","journal-title":"mBio"},{"key":"2025100905320898100_bib31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijantimicag.2018.06.005","article-title":"Resveratrol enhances the efficacy of aminoglycosides against Staphylococcus aureus","volume":"52","author":"Nohr-Meldgaard","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2025100905320898100_bib32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/14787210.2020.1756775","article-title":"Meropenem\/vaborbactam: a next generation beta-lactam beta-lactamase inhibitor combination","volume":"18","author":"Novelli","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025100905320898100_bib33","doi-asserted-by":"publisher","first-page":"e0025622","DOI":"10.1128\/aac.00256-22","article-title":"New perspectives on antimicrobial agents: imipenem-relebactam","volume":"66","author":"O'Donnell","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025100905320898100_bib34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000525807","article-title":"Effects of resveratrol on hepatitis B virus replication: in vitro and in vivo experiments","volume":"65","author":"Pan","year":"2022","journal-title":"Intervirology"},{"key":"2025100905320898100_bib35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41429-022-00555-1","article-title":"Synergistic antibacterial and anti-biofilm activities of resveratrol and polymyxin B against multidrug-resistant Pseudomonas aeruginosa","volume":"75","author":"Qi","year":"2022","journal-title":"J Antibiot"},{"key":"2025100905320898100_bib36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-3-030-16373-0_14","article-title":"Clinical use of polymyxin B","volume":"1145","author":"Rigatto","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2025100905320898100_bib37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.37201\/req\/s01.09.2022","article-title":"Ceftazidime-avibactam","volume":"35","author":"Sanz\u00a0Herrero","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"2025100905320898100_bib38","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1093\/cid\/ciaa121","article-title":"Clinical and Laboratory Standards Institute and European Committee on antimicrobial susceptibility testing position statements on polymyxin B and colistin clinical breakpoints","volume":"71","author":"Satlin","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025100905320898100_bib39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/pathogens9040296","article-title":"In vivo antimicrobial and wound-healing activity of resveratrol, dihydroquercetin, and dihydromyricetin against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans","volume":"9","author":"Shevelev","year":"2020","journal-title":"Pathogens"},{"key":"2025100905320898100_bib40","doi-asserted-by":"publisher","first-page":"1329307","DOI":"10.3389\/fphar.2024.1329307","article-title":"Ceftazidime-avibactam induced renal disorders: past and present","volume":"15","author":"Shi","year":"2024","journal-title":"Front Pharmacol"},{"key":"2025100905320898100_bib41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcma.2016.10.013","article-title":"Dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injuries","volume":"80","author":"Shoja","year":"2017","journal-title":"J Chin Med Assoc"},{"key":"2025100905320898100_bib42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/mdr.2018.0175","article-title":"Disinfectant resistance profiles and biofilm formation capacity of Escherichia coli isolated from retail chicken","volume":"25","author":"Sun","year":"2019","journal-title":"Microb Drug Resist"},{"key":"2025100905320898100_bib43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025100905320898100_bib44","doi-asserted-by":"publisher","first-page":"105762","DOI":"10.1016\/j.meegid.2025.105762","article-title":"Molecular sequence typing of carbapenem-resistant Acinetobacter baumannii clinical isolates: a comprehensive global update","volume":"131","author":"Taesoongnern","year":"2025","journal-title":"Infect Genet Evol"},{"key":"2025100905320898100_bib45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijantimicag.2016.09.010","article-title":"Pharmacokinetics\/pharmacodynamics of colistin and polymyxin B: are we there yet?","volume":"48","author":"Tran","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"2025100905320898100_bib46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","article-title":"International Consensus Guidelines for the Optimal Use of the Polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"2025100905320898100_bib47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13052-014-0093-3","article-title":"Resveratrol plus carboxymethyl-beta-glucan in children with recurrent respiratory infections: a preliminary and real-life experience","volume":"40","author":"Varricchio","year":"2014","journal-title":"Ital J Pediatr"},{"key":"2025100905320898100_bib48","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ijantimicag.2019.02.015","article-title":"Antibacterial and antifungal properties of resveratrol","volume":"53","author":"Vestergaard","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2025100905320898100_bib49","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"Walle","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"2025100905320898100_bib50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/biof.1410","article-title":"Metabolism and pharmacokinetics of resveratrol and pterostilbene","volume":"44","author":"Wang","year":"2018","journal-title":"Biofactors"},{"key":"2025100905320898100_bib51","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jpeds.2012.09.013","article-title":"A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children","volume":"162","author":"Williams","year":"2013","journal-title":"J Pediatr"},{"key":"2025100905320898100_bib52","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1186\/s12879-021-06719-y","article-title":"Efficacy and safety of polymyxin B in carbapenem-resistant Gram-negative organisms infections","volume":"21","author":"Xia","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025100905320898100_bib53","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/molecules24101849","article-title":"Biofilm formation in Acinetobacter baumannii: genotype-phenotype correlation","volume":"24","author":"Yang","year":"2019","journal-title":"Molecules"},{"key":"2025100905320898100_bib54","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/AAC.01705-13","article-title":"Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration","volume":"58","author":"Yapa","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2025100905320898100_bib55","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1517\/13543784.17.5.661","article-title":"Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms","volume":"17","author":"Yuan","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"2025100905320898100_bib56","doi-asserted-by":"publisher","first-page":"1024702","DOI":"10.3389\/fmicb.2022.1024702","article-title":"The combination effect of meropenem\/sulbactam\/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"2025100905320898100_bib57","doi-asserted-by":"publisher","first-page":"1395260","DOI":"10.3389\/fcimb.2024.1395260","article-title":"Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"2025100905320898100_bib58","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/antibiotics9080514","article-title":"Clinical and economic burden of carbapenem-resistant infection or colonization\u00a0caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: a multicenter study in China","volume":"9","author":"Zhen","year":"2020","journal-title":"Antibiotics"},{"key":"2025100905320898100_bib59","doi-asserted-by":"publisher","first-page":"9932218","DOI":"10.1155\/2021\/9932218","article-title":"Effects and mechanisms of resveratrol on aging and age-related diseases","volume":"2021","author":"Zhou","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"2025100905320898100_bib60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.burns.2020.10.016","article-title":"Resveratrol accelerates wound healing by attenuating oxidative stress-induced impairment of cell proliferation and migration","volume":"47","author":"Zhou","year":"2021","journal-title":"Burns"}],"container-title":["Journal of Applied Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jambio\/advance-article-pdf\/doi\/10.1093\/jambio\/lxaf240\/64373034\/lxaf240.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jambio\/article-pdf\/136\/10\/lxaf240\/64373034\/lxaf240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jambio\/article-pdf\/136\/10\/lxaf240\/64373034\/lxaf240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:32:15Z","timestamp":1760002335000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jambio\/article\/doi\/10.1093\/jambio\/lxaf240\/8262891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jambio\/lxaf240","relation":{},"ISSN":["1365-2672"],"issn-type":[{"value":"1365-2672","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,24]]},"article-number":"lxaf240"}}